BioGend Therapeutics Co (ROCO:6733) ROE % Adjusted to Book Value : -2.82% (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is BioGend Therapeutics Co ROE % Adjusted to Book Value?

BioGend Therapeutics Co's ROE % for the quarter that ended in Jun. 2024 was -15.18%. BioGend Therapeutics Co's PB Ratio for the quarter that ended in Jun. 2024 was 5.38. BioGend Therapeutics Co's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -2.82%.

BioGend Therapeutics Co ROE % Adjusted to Book Value Historical Data

The historical data trend for BioGend Therapeutics Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGend Therapeutics Co ROE % Adjusted to Book Value Chart

BioGend Therapeutics Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-6.43

-4.49

-5.59

-7.16

-3.80

BioGend Therapeutics Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-2.01	-3.74	-2.73	-0.94	-2.82

Competitive Comparison of BioGend Therapeutics Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, BioGend Therapeutics Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioGend Therapeutics Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioGend Therapeutics Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where BioGend Therapeutics Co's ROE % Adjusted to Book Value falls into.

BioGend Therapeutics Co ROE % Adjusted to Book Value Calculation

BioGend Therapeutics Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-19.02%	/	5.00
	=	-3.80%

BioGend Therapeutics Co's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-15.18%	/	5.38
	=	-2.82%

BioGend Therapeutics Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of BioGend Therapeutics Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

BioGend Therapeutics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioGend Therapeutics Co Ltd (ROCO:6733) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

4th Floor, Number 3, Park Street, Nangang District, Taipei, TWN, 115

Website

https://www.biogend.com.tw

BioGend Therapeutics Co Ltd is a Taiwan based company involved in developing regenerative bio-orthopaedic medicine to advance the clinical science of maintaining healthy joints in skeletal system. The Company is primarily engaged in the research and development of bone medical device related products. Its products under development include Big-001, Big-006 and Big-009.

BioGend Therapeutics Co Headlines

No Headlines